Home › Glycogen Storage Disease Type II › New York
Glycogen Storage Disease Type II clinical trials in New York
4 studies for Glycogen Storage Disease Type II are looking for participants at sites in New York.
Cities in New York
A Study to Evaluate Safety, Tolerability, and Efficacy of AB-1009 Gene Therapy (GAA Gene) in Adult Participants With Late-Onset Pompe Disease (PROGRESS-GT LOPD)
- NYU Langone, New York
RecruitingPhase 1/2
Ages 18 to 65 · All sexes · Updated Jul 20, 2026 · NCT07282847Pompe Disease Registry Protocol
- NYU Langone Health - Perlmutter Cancer Center - Huntington- Site Number : 840040, Huntington
- Northwell Health- Site Number : 840102, New Hyde Park
- Icahn School of Medicine at Mount Sinai- Site Number : 840005, New York
- and 4 more
RecruitingObservational study
All ages · All sexes · Updated Jun 23, 2026 · NCT00231400Pompe Pregnancy Sub-Registry
- New York University School Of Medicine- Site Number : 840040, New York
- Mt. Sinai School of Medicine- Site Number : 840005, New York
- Columbia University Irving Medical Center- Site Number : 157199, New York
RecruitingObservational study
All ages · Women · Updated Apr 16, 2026 · NCT00567073A Global Prospective Observational Registry of Patients With Pompe Disease
- NYU Neurogenetics, NYU Langone Medical Center, New York
RecruitingObservational study
All ages · All sexes · Updated Mar 10, 2026 · NCT06121011From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.